Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Adult |
Dose: Intravenous – According to the requirements Frequency: up to 100-drops/minute Note: The volume and rate of infusion will depend upon the requirements of the patients and the judgement of the physician. It usually varies with age, weight and clinical condition of the patient. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Treatment of hypokalemia Age: Birth to 16 years old |
Dose: 2–4 mEq/kg/day Frequency: Divided doses Note: Maximum Dose: 1 mEq/kg as a single dose or 40 mEq, whichever is lower; total daily dose should not exceed 100 mEq |
|
Indication: Maintenance or Prophylaxis of hypokalemia Age: Birth to 16 years old |
Dose: 1 mEq/kg/day Note: Maximum Dose: 3 mEq/kg/day |
Administration
- For intravenous use only
- Must be administered by healthcare professionals
Side Effect
- Reactions which may occur because of the solution or the technique of administration include febrile response
- infection at the site of injection
- venous thrombosis or phlebitis extending from the site of injection
- extravasation
- and hypervolemia
- Severe burning
- pain
- or swelling around the IV needle
- Warmth
- redness
- oozing
- or bleeding where the IV was placed
- fever
- ongoing cough
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Potassium-sparing diuretics (Amiloride, Eplerenone, Spironolactone, Triamterene), ACE Inhibitors (Captopril, Enalapril, Lisinopril, Ramipril, Benazepril, Fosinopril, Quinapril, Perindopril), Ciclosporin, Potassium-containing drugs
|
Potential interaction
|
|
Lithium
|
May affect serum concentrations
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Kidney Failure (Oliguria)
|
Cannot process electrolytes properly
|
|
Complete Kidney Failure (Anuria)
|
Dangerous electrolyte accumulation
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Should be stored at controlled room temperature.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.